Navigation Links
High Intensity Focused Ultrasound Physician Training Seminar in Mexico City
Date:3/16/2009

Leading HIFU device in Mexico for Minimally Invasive Treatment for Prostate Cancer and Benign Prostatic Hyperplasia draws attention from elite urologists

CHARLOTTE, N.C., March 16 /PRNewswire/ -- Mexico HIFU in conjunction with International HIFU, the Mexican and international entities of USHIFU, a global leader in the development, manufacturing and distribution of high intensity focused ultrasound (HIFU) technologies, will host the very first multiday Sonablate(R) HIFU physician training seminar in Mexico City, March 17-18, 2009 at Hospital Star Medica Santa Fe.

The two day training seminar using the Sonablate(R) HIFU device will host top urologists from several of Mexico's leading hospitals, including the Angeles Hospital Group, Clinical Lomas Altas and Hospital Star Medica. The training seminar will include an academic presentation which will provide an overview of the physics and science of HIFU as a therapy for prostate cancer and also discuss patient selection. Additionally, the seminar will incorporate a comprehensive review of international clinical outcomes and advanced one-on-one simulator training. The highlight for physicians attending the seminar will be observation and participation in live Sonablate(R) HIFU cases.

"There has been significant interest from the urology community within Mexico to bring this technology to Mexico's largest city. Within two days of announcing the training seminar, the limited number of spots were filled and we now have a waiting list of doctors from Guadalajara and Monterrey for the next HIFU physician training seminar," said Alex Gonzalez, Vice President of International Operations, USHIFU. "We are ecstatic to be working with such high caliber physicians and continue to spread awareness about HIFU for prostate cancer throughout Mexico."

Although this is the first training program of its kind in Mexico City, in the past four years, over 1000 patients have been treated in Mexico with minimally invasive Sonablate(R) HIFU in Guadalajara, Monterrey, Mexico City, Puerto Vallarta and Cancun.

About the Sonablate(R) 500

The Sonablate(R) 500 is a minimally invasive medical device that utilizes ultrasound energy to destroy tissue within the body. It was developed by FSI and is manufactured by Misonix, Inc. (Nasdaq: MSON) who also holds distribution rights in Europe. Takai Hospital Supply Ltd. and THS International distribute the Sonablate(R) 500 in Southeast Asia and the Middle East.

The Sonablate(R) 500 is not approved for use in the U.S. The Sonablate(R) 500 remains investigational in the U.S. and is being studied for the treatment of prostate cancer in clinical trials in the U.S. FDA has made no decision as to the safety or efficacy of the Sonablate(R) 500 for the treatment of prostate cancer.

About Mexico HIFU & International HIFU

Mexico HIFU is affiliated with USHIFU and International HIFU, the entity through which USHIFU conducts its international business operations and makes the HIFU technologies available to patients at centers outside the United States.

About USHIFU, LLC

USHIFU is a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound technologies.


'/>"/>
SOURCE US HIFU
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Supports Intensity Scale is effective for identifying needs in people with intellectual disability
2. The Supports Intensity Scale Assessment Can be Used to Build Robust Funding Methods for Developmental Disability Services, New Research Reveals
3. Low-intensity case management cuts COPD-related hospital visits in half
4. High-intensity chemotherapy does not improve survival in small cell lung cancer
5. Low-intensity exercise reduces fatigue symptoms by 65 percent, study finds
6. Esphera3 International Founded on Patient Focused Care
7. Frost & Sullivan Recognizes Strategic Healthcare Programs for Best Practices in Focused Innovation
8. Fertility Focused Acupuncture NW & Associates to Open Clinic in Tacoma
9. Carefx Reports 200% Year-Over-Year Revenue Growth in 2008 as Demand Grows for Solutions Focused on Clinical Decision Making
10. NQFs Corrigan Tells Senate Committee That Investing in Health IT Holds Great Promise If It is Focused on Wringing Out Efficiencies and Coordinating Patient Care
11. WeissComm Group Acquires Strategic Branding Firm ODA and Enters Alliance With Patient-Focused Health Advocacy Strategies to Diversify Business and Expand Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... Why does the prevalence of obesity continue to ... includes a fresh look into the cause of obesity in his new book “Body ... the knowledge needed to lead a healthy life. Proietto said understanding the regulation of ...
(Date:12/6/2016)... ... ... It can be argued that people these days spend as much time searching ... their human friends and family. As pets have assumed a bigger role in ... pet products has also increased. , For this reason, America’s Pet Health ...
(Date:12/6/2016)... ... December 06, 2016 , ... The Behavioral ... of Distinction, recognizing the organization as a top behavioral service provider in the ... of clinical quality, staff satisfaction and qualifications, and consumer satisfaction. These areas are ...
(Date:12/6/2016)... ... December 06, 2016 , ... Gateway Analytical, ... offering HIAC particle counting and sizing services for USP 788 and 789 particulate ... new service as a response to the needs of pharmaceutical and medical device ...
(Date:12/6/2016)... , ... December 06, 2016 ... ... on Friday, November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. ... eye-catching label design. Featuring one of the world’s most powerful antioxidants, molecular ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... 2016  Viking Therapeutics, Inc. ("Viking") (NASDAQ: ... on the development of novel therapies for metabolic ... Food and Drug Administration (FDA) has granted orphan ... X-linked adrenoleukodystrophy (X-ALD).  VK0214 is a novel, orally ... regulates the expression of genes believed to be ...
(Date:12/6/2016)... 2016 Breast Pump Market size is estimated ... by Global Market Insights, Inc. Continue Reading ... ... , , ... women employment rates and rising consumer awareness regarding importance of breast feeding will ...
(Date:12/6/2016)... , Dec. 6, 2016 In this ... reason to be hopeful.  A special kind of sunglasses, ... less anxious life. Photo - ... Robert Buck, the psychotherapist who developed and patented ... approach to overcoming anxiety and worry.  "Anxiety doesn,t ...
Breaking Medicine Technology: